Search

Search Constraints

You searched for: Author/Creator Schembri, Gabriel

Search Results

1. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis. Issue 1 (December 2016)

3. Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial*. Issue 3 (4th May 2017)

4. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

8. O023 Feasibility study to determine the time taken for NAATs tests to become negative following treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in men and women. (30th June 2016)

10. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Issue 10013 (2nd January 2016)